Beijing Chao Yang Hospital: Diabetes Mellitus, Type 2 trials
The registry lists 10 Diabetes Mellitus, Type 2 studies with Beijing Chao Yang Hospital as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 4 4No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 DiabetesNot yet recruitingNCT07520305Not applicable
- Sitagliptin for the Treatment of Type 2 DiabetesRecruitingNCT04495881Phase 4
- Efficacy of Lactobacillus Paracasei LC19 on Type 2 DiabetesCompletedNCT06639425Not applicable
- Sitagliptin in Combination With Beidougen Capsule for Type 2 DiabetesStatus unknownNCT05667220Phase 4
- A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or HyperlipidemiasStatus unknownNCT04660630Not applicable
- The Effect of Exenatide on Fasting Bile AcidsCompletedNCT04303819
- Effectiveness of SCDM in Patients With Type 2 DiabetesStatus unknownNCT04259489Not applicable
- Effectiveness of Shared Care Diabetes Management in Patients With Type 2 DiabetesStatus unknownNCT04100278Not applicable
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 DiabetesCompletedNCT03297879Phase 4
- Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 DiabetesStatus unknownNCT02583438Phase 4